MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
1.270
+0.090 (7.63%)
Apr 17, 2025, 4:00 PM EDT - Market closed
MacroGenics Stock Forecast
MGNX's stock price has decreased by -92.39% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for MacroGenics stock have an average target of 6.83, with a low estimate of 2.00 and a high estimate of 14. The average target predicts an increase of 437.80% from the current stock price of 1.27.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for MacroGenics stock from 10 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 8 | 8 | 8 | 8 | 8 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $4 → $2 | Hold | Maintains | $4 → $2 | +57.48% | Mar 25, 2025 |
| JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $4 | Hold | Reiterates | $4 | +214.96% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $4 | Hold | Reiterates | $4 | +214.96% | Sep 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $4 | Hold | Reiterates | $4 | +214.96% | Aug 21, 2024 |
Financial Forecast
Revenue This Year
38.18M
from 149.96M
Decreased by -74.54%
Revenue Next Year
69.06M
from 38.18M
Increased by 80.86%
EPS This Year
-2.96
from -1.07
EPS Next Year
-1.72
from -2.96
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 84.2M | 239.9M | 82.4M | ||
| Avg | 38.2M | 69.1M | 36.9M | ||
| Low | 20.8M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -43.8% | 528.4% | 19.4% | ||
| Avg | -74.5% | 80.9% | -46.6% | ||
| Low | -86.1% | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.50 | -0.20 | -1.76 |
| Avg | -2.96 | -1.72 | -2.41 |
| Low | -3.09 | -3.09 | -3.58 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.